company background image
BRKR logo

Bruker NasdaqGS:BRKR Stock Report

Last Price

US$66.79

Market Cap

US$9.8b

7D

3.5%

1Y

-11.4%

Updated

18 Jun, 2024

Data

Company Financials +

BRKR Stock Overview

Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.

BRKR fundamental analysis
Snowflake Score
Valuation5/6
Future Growth2/6
Past Performance6/6
Financial Health4/6
Dividends0/6

Bruker Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Bruker
Historical stock prices
Current Share PriceUS$66.79
52 Week HighUS$94.86
52 Week LowUS$53.79
Beta1.25
1 Month Change-11.03%
3 Month Change-28.16%
1 Year Change-11.41%
3 Year Change-8.53%
5 Year Change38.11%
Change since IPO189.60%

Recent News & Updates

Bruker Corporation's (NASDAQ:BRKR) Business Is Yet to Catch Up With Its Share Price

Jun 09
Bruker Corporation's (NASDAQ:BRKR) Business Is Yet to Catch Up With Its Share Price

Bruker: A Confusing Acquisition Spree

May 31

Recent updates

Bruker Corporation's (NASDAQ:BRKR) Business Is Yet to Catch Up With Its Share Price

Jun 09
Bruker Corporation's (NASDAQ:BRKR) Business Is Yet to Catch Up With Its Share Price

Bruker: A Confusing Acquisition Spree

May 31

Bruker's (NASDAQ:BRKR) Promising Earnings May Rest On Soft Foundations

May 09
Bruker's (NASDAQ:BRKR) Promising Earnings May Rest On Soft Foundations

Bruker Corporation: An Aggressive Acquisition Strategy

Apr 24

Bruker Offers Upside With Key Enabling Technologies For Future Bio-Pharma Research

Apr 11

Calculating The Fair Value Of Bruker Corporation (NASDAQ:BRKR)

Jan 22
Calculating The Fair Value Of Bruker Corporation (NASDAQ:BRKR)

There's Reason For Concern Over Bruker Corporation's (NASDAQ:BRKR) Price

Jan 08
There's Reason For Concern Over Bruker Corporation's (NASDAQ:BRKR) Price

Should You Be Adding Bruker (NASDAQ:BRKR) To Your Watchlist Today?

Dec 26
Should You Be Adding Bruker (NASDAQ:BRKR) To Your Watchlist Today?

Is Bruker Corporation (NASDAQ:BRKR) Potentially Undervalued?

Nov 06
Is Bruker Corporation (NASDAQ:BRKR) Potentially Undervalued?

Is Bruker (NASDAQ:BRKR) Using Too Much Debt?

Oct 23
Is Bruker (NASDAQ:BRKR) Using Too Much Debt?

Here's Why Bruker (NASDAQ:BRKR) Has Caught The Eye Of Investors

Sep 25
Here's Why Bruker (NASDAQ:BRKR) Has Caught The Eye Of Investors

Does This Valuation Of Bruker Corporation (NASDAQ:BRKR) Imply Investors Are Overpaying?

Aug 09
Does This Valuation Of Bruker Corporation (NASDAQ:BRKR) Imply Investors Are Overpaying?

Is Now The Time To Look At Buying Bruker Corporation (NASDAQ:BRKR)?

Jul 27
Is Now The Time To Look At Buying Bruker Corporation (NASDAQ:BRKR)?

Bruker (NASDAQ:BRKR) Has A Pretty Healthy Balance Sheet

Jul 11
Bruker (NASDAQ:BRKR) Has A Pretty Healthy Balance Sheet

If EPS Growth Is Important To You, Bruker (NASDAQ:BRKR) Presents An Opportunity

Jun 26
If EPS Growth Is Important To You, Bruker (NASDAQ:BRKR) Presents An Opportunity

Is It Time To Consider Buying Bruker Corporation (NASDAQ:BRKR)?

Apr 25
Is It Time To Consider Buying Bruker Corporation (NASDAQ:BRKR)?

These 4 Measures Indicate That Bruker (NASDAQ:BRKR) Is Using Debt Reasonably Well

Apr 07
These 4 Measures Indicate That Bruker (NASDAQ:BRKR) Is Using Debt Reasonably Well

Bruker (NASDAQ:BRKR) Ticks All The Boxes When It Comes To Earnings Growth

Feb 20
Bruker (NASDAQ:BRKR) Ticks All The Boxes When It Comes To Earnings Growth

Why Bruker Corporation (NASDAQ:BRKR) Could Be Worth Watching

Jan 17
Why Bruker Corporation (NASDAQ:BRKR) Could Be Worth Watching

Shareholder Returns

BRKRUS Life SciencesUS Market
7D3.5%-1.4%1.6%
1Y-11.4%0.8%22.3%

Return vs Industry: BRKR underperformed the US Life Sciences industry which returned 0.8% over the past year.

Return vs Market: BRKR underperformed the US Market which returned 22.3% over the past year.

Price Volatility

Is BRKR's price volatile compared to industry and market?
BRKR volatility
BRKR Average Weekly Movement6.0%
Life Sciences Industry Average Movement7.0%
Market Average Movement5.7%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market2.8%

Stable Share Price: BRKR's share price has been volatile over the past 3 months.

Volatility Over Time: BRKR's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19919,707Frank Laukienwww.bruker.com

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits.

Bruker Corporation Fundamentals Summary

How do Bruker's earnings and revenue compare to its market cap?
BRKR fundamental statistics
Market capUS$9.81b
Earnings (TTM)US$401.60m
Revenue (TTM)US$3.00b

25.2x

P/E Ratio

3.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BRKR income statement (TTM)
RevenueUS$3.00b
Cost of RevenueUS$1.48b
Gross ProfitUS$1.52b
Other ExpensesUS$1.12b
EarningsUS$401.60m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)2.65
Gross Margin50.61%
Net Profit Margin13.38%
Debt/Equity Ratio94.9%

How did BRKR perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

7%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.